<DOC>
	<DOCNO>NCT01896635</DOCNO>
	<brief_summary>The purpose study determine whether fecal microbiota transplantation ( FMT ) safe efficacious treatment chronic active ulcerative colitis ( UC ) conduct randomise control trial</brief_summary>
	<brief_title>Faecal Microbiota Transplantation Ulcerative Colitis</brief_title>
	<detailed_description>This study involve assessment safety efficacy FMT treatment induction remission patient mild moderate ulcerative colitis . It double blind study patient randomise 1:1 manner either active placebo therapy</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Ulcerative colitis &gt; 3 month duration Active mildmoderate ulcerative colitis ( Mayo 410 ) Ulcerative colitis extent except isolated proctitis &lt; 5cm Live within drive distance clinical site ( attend multiple study visit ) Pregnancy Active gastrointestinal infection Other gastrointestinal disease / comorbidities Prior colonic surgery Recent antibiotic probiotic use Prednisone &gt; 20mg Monoclonal antibody immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Fecal Transplantation</keyword>
	<keyword>Fecal Microbiota Transplantation</keyword>
</DOC>